Navigation Links
Inverness Medical Innovations Announces First Quarter 2009 Results
Date:4/27/2009

----- ----- ----- Net income (loss) $6,291 $49,800 $56,091 ====== ======= ======= Preferred stock dividends $(5,520) $(5,520) Net income (loss) available to common stockholders - basic $771 $50,571 ==== ======= Net income (loss) per common share: Basic $0.01 $0.64 ===== ===== Diluted $0.01 (i) $0.61(k) ===== ===== Weighted average common shares - basic 78,614 78,614 Weighted average common shares - diluted 79,637 (i) 93,812(k) Three Months Ended March 31, 2008 --------------------------------- Non-GAAP Adjusted Non-GAAP Cash GAAP Adjustments Basis (a) ---- ------------- ----------- Net product sales and services revenue $361,361 $- $361,361 License and royalty revenue 10,872 - 10,872 ------ - ------ Net revenue 372,233 372,233 Cost of net r
'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Inverness Completes Acquisition of Cholestech
2. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
3. Inverness Medical Innovations Acquires Alere Medical
4. Inverness Medical Innovations Announces Closing of Public Offering
5. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
6. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
10. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
11. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , Innovative medical app...09 conference , San Cleme...reg;, maker of breakthrough medical apparel, today...h are on display at Medica 2009, a leading interna... Dusseldorf, Germany. Medelita inaugurates its men...
(Date:11/20/2009)... , , Pioneering Neurologist Closer to Unde...ON, Nov. 20 Dr. Jeremy ...cal School and neurologist at the Massachusetts Ge..., presented his laboratory,s research on the new f...of the MINDlink Foundation. ,, Dr. Schmahmann i...
(Date:11/20/2009)... , Senators and Congressm...Trouble Over their Health Care Vote , ...009 -- Senators and congressmen running for re-ele...by political guru Charlie Cook, may come to regret...lth care bill, according to a breaking Zogby Inter...
(Date:11/20/2009)... , , WINSTON-SALEM, N.C., Nov. 20 /PRNewsw...but he is on a mission to redefine what it means t...ofessional counselor with a specialty in family co... at Wake Forest University, Gladding says research...ten leads to sadness and even depression during th...
(Date:11/20/2009)... , Spot blood pressure readings in children with ...ension even during doctor,s office visits increa...cording to research from Johns Hopkins Children,s ...dings appears online in the Journal of American So...ood pressure measurements obtained during regular ...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...ctor Dr.Sanjiv Malik is among 65 "caring" physicia...he World Medical Association (WMA).// The Ind...f many countries including the UK and USA are ver...ery popular with their patients Dr.Malik...
...tific Advisory Committee for Nutrition in United K... with folic acid/Vitamin B12.// Folic acid act...orn babies and pregnant women has it protects newb... abnormalities. Folic acid helps to increase blood...
...en Hello" grants that were designed to nlure healt...ortage of NHS personnel has failed for the dental ...eported. //The scheme has allocated a ?10,000 gran...sts have shifted to Lothians meaning that an addit...
...r of children affected by AIDS/HIV in India has co... than 340 infant deaths in New Delhi can be attrib...cerns regarding the prevalence of the disease amon...imated 2, 02,000 children suffer from HIV/AIDS in ...
...in Atlantic Canada suffering from chronic pain hav...ent in pain clinics. The survey was conducted by A... The survey found that more than 460 000 chron...ill lots of emergency patients are referred to the...
...ppines health department has banned smoking within...east Asian games.// Health Secretary Francisco ...loyed in all venues to enforce the ban at the bien... the spectators. 'Participants, officials and...
Other Medicine News:Health News:Good Response from Pregnant Women in Delhi for Free ART Therapy 2
(Date:11/20/2009)...N LAKES, N.J., Nov. 20 B...oday announced the completion of its acquisition o...pany that develops and manufactures molecular diag...ay 2009, BD and HandyLab announced an exclusive ag...lar assays on the HandyLab Jaguar(TM) platform, th...
(Date:11/19/2009)...NGHAM, Ala., Nov. 19 Bio... announced the pricing of a public offering of 5,0...re, resulting in gross proceeds of $48.75 million....pursuant to an effective shelf registration statem...nge Commission. BioCryst has also granted the und...
(Date:11/19/2009)...N VIEW, Calif., Nov. 19 ...unced today that its corporate presentation will b...y Health Care Conference on Wednesday, December 2,... will be webcast from The New York Palace Hotel in... Alexza President and CEO. ,, To access the l...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 1AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 2AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 3AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 4AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 5AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 6AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 7Many Health Care Workers May Shun Swine Flu Shot 55387 1Many Health Care Workers May Shun Swine Flu Shot 55387 2Danaher to Present at Morgan Stanley Global Industrials Conference 55383 1
... FOSTER CITY, Calif.--(BUSINESS WIRE)--June 25, 20...unced that Study 103, a,Phase III clinical trial e...iread(R) (tenofovir disoproxil fumarate or tenofov... hepatitis B virus,(HBV) infection, met its primar...non-inferior to the company,s once-daily antiviral...
... PHILADELPHIA, June 25, 2007 /PRNewswire-USNewswir...among them, neuroblastoma is a,special case, accou...15 percent of childhood cancer deaths. It typicall... in the neck, chest, and,pelvis, developing in the... , Neuroblastoma is what physicians call a heterog...
Other Medicine Technology:Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6Neuroblastoma Expert Reviews Progress and Challenges in Fighting,Difficult Pediatric Cancer 2Neuroblastoma Expert Reviews Progress and Challenges in Fighting,Difficult Pediatric Cancer 3
10 L Low Rentention Pipette Tip
10 L Pipette Tip
...s a revolutionary advancement in spine surgery, pr...nd manage their patients. The eDISC's unmatched re... from 1st and 2nd generation designs., ,Create... spine, the eDISC restores and maintains 6 degrees...
...ant Tips offer a safe alternative to using positiv...r applications such as PCR(a), pipetting radioacti... Tips are excellent for tissue culture, gel loadin...ps prevent aerosol contaminants and liquids from r...
Medicine Products: